SAN FRANCISCO, CA, Artera, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, launches publicly today with $90 million in funding.
SAN FRANCISCO, CA, Artera, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, launches publicly today with $90 million in funding.
Leave a Comment
Your email address will not be published. Required fields are marked with *